{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:27:09Z","timestamp":1794587229925,"version":"4.9.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,19]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Omentin-1 protein has protective effects against coronary artery disease (CAD). The Val109Asp polymorphism (rs2274907) in the Omentin-1 gene has been associated with CAD risk, but this relationship has not been investigated in patients with type 2 diabetes mellitus (T2DM). To investigate the association between the Omentin-1 Val109Asp polymorphism and CAD risk in Han Chinese patients with T2DM. This case-control study enrolled 465 Han Chinese patients with T2DM from July 2008 to September 2015. Participants were classified as CAD-positive (coronary stenosis\u2005&gt;\u200550% in at least 1 major vessel, n\u2005=\u2005249) or CAD-negative (n\u2005=\u2005216). The Val109Asp polymorphism was genotyped using PCR-RFLP. Logistic regression analysis was performed to assess the association between genotypes and CAD risk, with adjustment for potential confounders including age, sex, smoking status, hypertension, dyslipidemia, diabetes duration, body mass index, and fasting glucose. The A allele frequency was higher in CAD patients than in controls (34.5% vs 27.5%; OR\u2005=\u20051.386;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.026). Under the dominant model, TA\/AA carriers had increased CAD risk compared with TT homozygotes (adjusted OR\u2005=\u20051.509, 95% CI: 1.025\u20132.222;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.037). Stratified analyses showed that smokers carrying the A allele exhibited further elevated CAD risk (adjusted OR\u2005=\u20051.82, 95% CI: 1.02\u20133.27). The Omentin-1 Val109Asp polymorphism is associated with increased CAD risk in Han Chinese patients with T2DM under the dominant genetic model. Stratified findings suggest that smoking may further heighten CAD susceptibility among A-allele carriers. Integrating genetic and lifestyle factors may improve cardiovascular risk assessment in this population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049405","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:00:16Z","timestamp":1782108016000},"page":"e49405","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Omentin-1 Val109Asp polymorphism and increased coronary artery disease risk in smokers with type 2 diabetes"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7395-5041","authenticated-orcid":false,"given":"Dahong","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"},{"name":"Department of Endocrinology, Changping District Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linchao","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Difei","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University First Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261113","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-20261113","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","article-title":"Type 2 diabetes.","volume":"389","author":"Chatterjee","year":"2017","journal-title":"Lancet"},{"key":"R3-20261113","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death.","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-20261113","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/eurheartj\/ehad380","article-title":"Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study.","volume":"44","author":"Cho","year":"2023","journal-title":"Eur Heart J"},{"key":"R5-20261113","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/bmm-2023-0113","article-title":"Admission triglyceride-glucose index is predictor of long-term mortality and appropriate implantable cardiac defibrillator therapy in patients with heart failure.","volume":"17","author":"\u00d6zcan","year":"2023","journal-title":"Biomark Med"},{"key":"R6-20261113","doi-asserted-by":"crossref","first-page":"280","DOI":"10.12997\/jla.2022.11.3.280","article-title":"The triglyceride-glucose index can predict long-term major adverse cardiovascular events in Turkish patients with high cardiovascular risk.","volume":"11","author":"Hayiro\u011flu","year":"2022","journal-title":"J Lipid Atheroscler"},{"key":"R7-20261113","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology.","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"R8-20261113","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/cvr\/cvw016","article-title":"Counteractive effects of omentin-1 against atherogenesis\u2020.","volume":"110","author":"Watanabe","year":"2016","journal-title":"Cardiovasc Res"},{"key":"R9-20261113","first-page":"e17347","article-title":"Association between coronary artery disease and plasma omentin-1 levels.","volume":"13","author":"Bai","year":"2021","journal-title":"Cureus"},{"key":"R10-20261113","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/aps.2011.26","article-title":"Association of serum omentin-1 levels with coronary artery disease.","volume":"32","author":"Zhong","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"R11-20261113","doi-asserted-by":"crossref","first-page":"e59697","DOI":"10.1371\/journal.pone.0059697","article-title":"Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies.","volume":"8","author":"Greulich","year":"2013","journal-title":"PLoS One"},{"key":"R12-20261113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2840-6-3","article-title":"Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases.","volume":"6","author":"Sch\u00e4ffler","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"R13-20261113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clinbiochem.2021.11.005","article-title":"The impact of omentin-1 gene polymorphisms (rs2274907 and rs2274908) on serum lipid concentrations and coronary artery disease in a sample of Iraqi individuals (A pilot study).","volume":"100","author":"Al-Barqaawi","year":"2022","journal-title":"Clin Biochem"},{"key":"R14-20261113","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0218492317699752","article-title":"Omentin Val109Asp polymorphism and risk of coronary artery disease.","volume":"25","author":"Jamshidi","year":"2017","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"R15-20261113","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5152\/akd.2013.4932","article-title":"Association of omentin Val109Asp polymorphism with coronary artery disease.","volume":"14","author":"Y\u00f6r\u00fck","year":"2014","journal-title":"Anadolu Kardiyol Derg"},{"key":"R16-20261113","first-page":"1128","article-title":"Association of single nucleotide missence polymorphism Val109Asp of omentin-1 gene and coronary artery disease in Pakistani population: multicenter study.","volume":"33","author":"Nazar","year":"2017","journal-title":"Pak J Med Sci"},{"key":"R17-20261113","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jpm9020030","article-title":"Evaluation of the association of omentin 1 rs2274907 A>T and rs2274908 G>A gene polymorphisms with coronary artery disease in Indian population: a case control study.","volume":"9","author":"Jha","year":"2019","journal-title":"J Pers Med"},{"key":"R18-20261113","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update.","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R19-20261113","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis.","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-20261113","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrg1578","article-title":"Gene-environment interactions in human diseases.","volume":"6","author":"Hunter","year":"2005","journal-title":"Nat Rev Genet"},{"key":"R21-20261113","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrg.2016.160","article-title":"Genetics of coronary artery disease: discovery, biology and clinical translation.","volume":"18","author":"Khera","year":"2017","journal-title":"Nat Rev Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:00:26Z","timestamp":1794585626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":21,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049405","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"2026-03-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}